These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13774428)

  • 21. Daily changes in serum glutamic oxalacetic acid transaminase, with reference to the clinical aspects.
    TOIVANEN P; HARRI J; KALLIOMAKI JL
    Cardiologia (Basel); 1963; 42():391-4. PubMed ID: 13985298
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the value of transaminase determinations in blood donors].
    KREBS HJ; LINDNER H; SACHS V; WALTHER J
    Med Welt; 1961 Jun; 25():1342-3. PubMed ID: 13754175
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood glutamic oxalacetic and glutamic pyruvic transaminases in the normal newborn infant and in the principle forms of icterus of the first months of life].
    MOLLICA F; BONGIORNO V
    Lattante; 1960 Jun; 31():309-23. PubMed ID: 14423427
    [No Abstract]   [Full Text] [Related]  

  • 24. [Critical analysis of the blood glutamic oxalacetic and glutamic pyruvic transaminases in hepatology (Apropos of 100 paired determinations accomplished during the observation of 50 patients)].
    MORETTI G; STAEFFEN J; BALLAN P; DEMANGE G
    J Med Bord; 1959 Sep; 136():1043-8. PubMed ID: 14424078
    [No Abstract]   [Full Text] [Related]  

  • 25. The relative value of serum and plasma transaminase determinations.
    BESSMAN AN; HAWKINS R; MIRICK GS
    Bull Johns Hopkins Hosp; 1960 Mar; 106():178-84. PubMed ID: 13800112
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent clinical experiences with serum aminopherase (transaminase) determinations.
    MERRILL JM; LEMLEY-STONE J; GRACE JT; MENEELY GR
    J Am Med Assoc; 1956 Apr; 160(17):1454-6. PubMed ID: 13306575
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes in glutamic acid-oxaloacetic acid-transaminase activity in the liver and kidneys on the effect of high doses of Pyramidon (aminopvrine).
    FAZEKAS IG; FAZEKAS AG; RENGEI B
    Can J Biochem Physiol; 1961 Jul; 39():1189-91. PubMed ID: 13698454
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum transaminase determinations as a diagnostic aid in myocardial infarction.
    SHABETAI R; IGLAUER A; ANDERSON DM
    Br Med J; 1957 Mar; 1(5018):555-7. PubMed ID: 13404232
    [No Abstract]   [Full Text] [Related]  

  • 29. Transaminase; importance of serial determinations of serum glutamic oxalacetic transaminase in differential diagnosis of myocardial infarction.
    FRIMPTER GW
    Northwest Med; 1959 Jun; 58(6):831-6. PubMed ID: 13667079
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies and research on glutamic-oxalacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) in pediatrics].
    ALBORES JM; PLATER ED; CERVIO CASTELLI MD
    Sem Med; 1962 Mar; 120():469-93. PubMed ID: 13860143
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in toxemia of pregnancy.
    BORGLIN NE
    J Clin Endocrinol Metab; 1959 Apr; 19(4):425-31. PubMed ID: 13654473
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activity of lactic acid dehydrogenase and glutamic-oxalacetic and glutamic-pyruvic transaminases in newborn infants].
    HERINGOVA A
    Cesk Pediatr; 1961 Sep; 16():803-8. PubMed ID: 13906675
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum glutamic oxalacetic transaminase (SGO-T) determinations in prostatic surgery: report of cases.
    REAGAN JR; TAYLOR FW; HIGGS RE; DAYDEN CB; IRVINE EW; IRVINE ES
    J Urol; 1961 Mar; 85():334-5. PubMed ID: 13740081
    [No Abstract]   [Full Text] [Related]  

  • 34. [The activity of glutamic oxalacetic and glutamic pyruvic transaminase in blood platelets].
    BABINI B; MUSIANI S
    Clin Pediatr (Bologna); 1959 Aug; 41():651-5. PubMed ID: 13795492
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of liver damage on serum glutamic oxalacetic transaminase and glutamic pyruvic transaminase.
    RANGAM CM; SHRIVASTAVA KK; GUPTA JC
    J Indian Med Assoc; 1962 Apr; 38():395-9. PubMed ID: 14490264
    [No Abstract]   [Full Text] [Related]  

  • 36. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. II. Comparison of serum transaminase activity with determinations of serum aldolase, cholesterol, alpha2-globulin, iron, copper and lactic dehydrogenase.
    HANSON A; BIORCK G
    Acta Med Scand; 1957 Jun; 157(6):493-502. PubMed ID: 13434796
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of blood glutamic oxalacetic and glutamic pyruvic transaminase activity in heart diseases].
    RAVAIOLI P; BRACONI M
    Atti Soc Ital Cardiol; 1959; 21(2)():Comunicazioni 95-7. PubMed ID: 14436519
    [No Abstract]   [Full Text] [Related]  

  • 38. [The behavior of glutamic-oxalacetic and glutamic-pyruvic transaminases in leptospirosis].
    MONTEVERDE A; FUMAGALLI E
    Minerva Med; 1959 Aug; 50():2600-4. PubMed ID: 14423736
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum transaminase activity (glutamic-oxalacetic and glutamic-pyruvic transaminases) in destructive pulmonary diseases.
    BERTOLINI AM; GUARDAMAGNA C; MASSARI N; QUARTO DI PALO F
    Acta Vitaminol; 1958 Aug; 12(4):159-61. PubMed ID: 13605960
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serum glutamic-oxalacetic and glutamic-pyruvic transaminases in myocardial infarct].
    FORTIN P; PERROTIN M
    Prog Med (Paris); 1959 Sep; 87():300-4. PubMed ID: 13824065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.